Glooko, a Mountain View, CA-based provider of diabetes data management has rasied $35 million in Series C funding led by Georgian Partners with participation from Insulet Corporation, Mayo Clinic, Canaan Partners, Social Capital, Medtronic and Samsung NEXT. The company plans to use the funding to expand its’ commercialization efforts in France, Germany, the U.K., Asia and the Middle East, and further development efforts in data analytics and artificial intelligence to provide personalized
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Medtronic, Aetna Form Outcomes-Based Partnership for Diabetic Patients
Medtronic, a medical technology provider has entered into a new outcomes-based, risk-sharing agreement with Aetna for type 1 and type 2 diabetes patients currently on multiple daily insulin injections for their diabetes management. The agreement will measure health outcomes for a patient with diabetes who transition to Medtronic’s insulin pump therapy that constantly self-adjusts to keep patients’ blood sugar levels in range based on their personalized needs.This outcomes-based, risk-sharing
Read More
Study: Glooko’s Diabetes Mobile App Improved Glucose & A1C Rates
Diabetes data management company Glooko announced that its mobile app was associated with a drop in average blood glucose, estimated A1C (eA1C) and hyperglycemia rates in people with diabetes, according to results of two retrospective studies. Furthermore, usage of the Glooko mobile app was also associated with an increase in blood glucose test rate. Increased blood glucose testing rates have been shown to directly correlate with improvements in glycemic control, as evidenced by this
Read More
Livongo Launches New Direct-to-Consumer Diabetes Management Program
Livongo Health, a consumer digital health company focused on empowering people with chronic conditions to live better and healthier lives, today announced partnerships with the American Diabetes Association, Beyond Type 1, Diabetes Hands Foundation, and JDRF to launch the Livongo Family Care Plan. The Family Care Plan is a comprehensive direct-to-consumer diabetes management program for people with diabetes and those who love them.The partnership also provides everyone who subscribes to the
Read More
WellDoc Founders Launch FDA-Cleared Mobile Insulin Titration App for Diabetes Management
The team that created the first FDA-cleared mobile app for diabetes management at WellDoc has launched a completely new digital health company, Amalgam Rx. The new company is focused on developing next-generation, evidence-based digital therapies that empower and engage patients with chronic diseases. Amalgam’s first product, iSage Rx is the first FDA 510(k)-cleared, prescription-only, mobile insulin titration app of all brands of basal insulin including Lantus, Levemir, Toujeo, Tresiba and
Read More
DarioHealth Expands Cloud-based Diabetes Monitoring Devices to U.K. Market
DarioHealth, a Israel-based provider of cloud-based diabetes monitoring devices has announced the launch of a direct-to-consumer channel in the United Kingdom. Following the success of the direct-to-consumer channels in the U.S. and Australia, DarioHealth will leverage its knowledge to provide new opportunities for the greater U.K. diabetes community to analyze and personalize their treatment.Until today, DarioHealth was only available through pharmacies and diabetes educators in the U.K. Now,
Read More
Livongo Health Raises $52.5M to Expand Diabetes Management to International Markets
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better has raised $52.5 million in growth funding co-led by existing investor General Catalyst and international investment company Kinnevik. Singapore-based EDBI, American Investment Holdings LLC, and Microsoft Ventures also joined the round including participation from previous investors. The company plans to utilize the funding to expand its diabetes management to international markets
Read More
NHS’ Salford Royal Trust, Validic Partner to Integrate Patient-Generated Health Data Into EHR
The Royal Salford Trust of the NHS and digital health integration platform Validic have announced a partnership centering around innovation with health data, research & remote care services. The partnership will enable the integration of patient-generated health data from in-home medical devices, wearables and consumer health apps into the EHR. The goal of this initiative is to identify how the integration of this data yields a measurable difference in patient care, outcomes and
Read More
Northwell Health, GE Ventures Form $200M Alliance to Develop, Commercialize Solutions in Bioelectronic Medicine
Today, GE Ventures announced a strategic partnership with Northwell Health’s Feinstein Institute for Medical Research providing up to $200 million in joint funding over seven years to support the opening of a new Center for Bioelectronic Medicine (CBEM), and advance diagnostic and therapeutic solutions for Alzheimer’s, cancer, diabetes, hypertension and more. The new alliance will greatly build upon groundbreaking work that started between the Feinstein Institute and a team of GE scientists
Read More
Ascensia Diabetes Care, Glooko Partner to Integrate Diabetes Data for Consumers
Ascensia Diabetes Care and Glooko, a remote patient monitoring platform for diabetes has announced an integration partnership to improve diabetes data management and analytics. The integration includes Glooko's Diabetes Data Management Platform and Ascensia's blood glucose monitoring systems that will allow people with diabetes and health care professionals to access and analyze highly accurate blood glucose data through the digital platform of their choice. The collaboration includes all
Read More